STAAR Surgical sinks as it plans to terminate sale to Alcon

STAAR Surgical sinks as it plans to terminate sale to Alcon
STAAR Surgical vote on Alcon may be delayed again - report
STAAR Surgical gains as special meeting on Alcon deal is adjourned
STAAR Surgical gains as proxy adviser ISS supports revised Alcon deal
STAAR Surgical falls as proxy adviser recommends against revised Alcon deal
STAAR Surgical holder Yunqi Capital still against sale to Alcon
1.39BUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US8523123052
CUSIP
852312305
Sector
Healthcare
Industry
Medical Instruments & Supplies
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
0.76
Book Value
6.97
Dividend Share
-
Dividend Yield
-
Earnings Share
-1.62
Wall Street Target Price
21.11
EPS Estimate Current Year
0.55
EPS Estimate Next Year
0.77
EPS Estimate Current Quarter
0.1667
EPS Estimate Next Quarter
0.0467
Most Recent Quarter
-
Revenue TTM
239,442,000
Gross Profit TTM
182,420,000
EBITDA
-37,419,000
Profit Margin
-33.60%
Return On Assets TTM
-5.95%
Return On Equity TTM
-21.70%
Revenue Per Share TTM
4.831
Qtly Revenue Growth YOY
18.10%
Diluted Eps TTM
-1.62
Qtly Earnings Growth YOY
-10.50%
Trailing PE
0.00
Forward PE
95
Price Sales TTM
5.7868
Price Book MRQ
3.8609
Enterprise Value Revenue
4
Enterprise Value EBITDA
42
100.00
2.49%176.22
1.96%38.79
0.54%198.00
0.43%178.24
0.00%302.37
-2.95%144.00
-2.47%63.44
-0.53%203.72
-0.07%431.80
-0.01%